Bavencio

药品简介

Originator: Bavencio by EMD Serono, Inc. · Manufacturer: MERCK Pharma. Indication & Dosage: Bavencio (Avelumab), is a prescription medicine used to treat of adults with metastatic Merkel cell carcinoma (MCC). Avelumab is also approved for use in patients aged 12 years and older. It works by modulating the immune system to enhance its ability to identify and destroy cancer cells. Avelumab belongs to a class of medications known as monoclonal antibodies. Bavencio manufacturted by Merck Pharma Ltd. In USA. Avelumab is given by injection into a vein over 60 minutes as directed by your doctor, usually once every 2 weeks. Side Effects: The most common side effects of Avelumab are: Fatigue, Musculoskeletal pain, Rash, pruritus, nausea, constipation, diarrhea, cough, dyspnea, Peripheral edema (swelling of limbs), Decreased appetite. The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。